Related Experiment Video
Updated: Nov 11, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
An Open Access Database of Licensed Cancer Drugs
Pan Pantziarka1,2, Rica Capistrano I1, Arno De Potter3
1The Anticancer Fund, Brussels, Belgium.
Abstract:
A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for supportive care, diagnostic or other non-antineoplastic uses. We describe a methodology to combine and cleanse relevant data from multiple sources to produce an open access database of drugs licensed specifically for therapeutic antineoplastic purposes. The resulting list is provided as an open access database, (http://www.redo-project.org/cancer-drugs-db/), so that it may be used by researchers as input for further research projects, for example literature-based text mining for drug repurposing.
Insights
A comprehensive, open-access database of approved anticancer drugs was created by combining and cleansing data from multiple sources. This resource aids researchers in oncology drug discovery and repurposing efforts.
Area of Science:
- Oncology
- Pharmacology
- Bioinformatics
Background:
- Existing anticancer drug information is fragmented across various sources.
- Current databases often include non-antineoplastic drugs, complicating research.
- A unified, specialized list of antineoplastic agents is lacking.
Purpose of the Study:
- To develop a methodology for creating a comprehensive, open-access database of approved anticancer drugs.
- To curate a list of drugs licensed specifically for antineoplastic purposes.
- To provide a valuable resource for cancer research, including drug repurposing.
Main Methods:
- Data aggregation from multiple sources (regulatory authorities, national formularies, scientific agencies).
- Data cleansing and validation to ensure accuracy and relevance.
- Development of a methodology for systematic data integration.
Main Results:
- Creation of an open-access database of approved anticancer drugs.
- The database specifically lists drugs for therapeutic antineoplastic use.
- The database is accessible at http://www.redo-project.org/cancer-drugs-db/.
Conclusions:
- The developed methodology successfully created a specialized anticancer drug database.
- This open-access resource facilitates further research in oncology.
- The database supports initiatives like text mining for drug repurposing.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
10:38Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
Published on: December 16, 2022
Related Concept Videos
Treatment Resistant Cancers
Cancer
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis